UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $523.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
Why Anthropic's IPO contrasts the 'cult of Elon Musk' at SpaceX and Tesla
Yahoo2 Hours Ago
Tesla Stock Has Room to Run, If History Is Any Indicator
Yahoo2 Hours Ago
Will AI Product Push Change Vertiv Stock Narrative Ahead Of Q3 Earnings
Yahoo2 Hours Ago
Apple (AAPL) Could Be 36% Overvalued As AI Launches Meet iPhone Duo Scrutiny
Yahoo2 Hours Ago
3 Types of Investors Who Should Avoid SpaceX and Tesla Stocks as the Companies Explore a Potential Merger
Yahoo3 Hours Ago
Alpaca · SIPUpdated 16:10 NY15 Minutes DelayedMay Be Out Of Date
